Skip to Content
Merck
  • Subsets of ATP-sensitive potassium channel (KATP) inhibitors increase gap junctional intercellular communication in metastatic cancer cell lines independent of SUR expression.

Subsets of ATP-sensitive potassium channel (KATP) inhibitors increase gap junctional intercellular communication in metastatic cancer cell lines independent of SUR expression.

FEBS letters (2011-11-29)
Thomas M Bodenstine, Kedar S Vaidya, Aimen Ismail, Benjamin H Beck, Anne R Diers, Mick D Edmonds, Gina T Kirsammer, Aimee Landar, Danny R Welch
ABSTRACT

Gap junctional intercellular communication (GJIC) regulates cellular homeostasis by propagating signaling molecules, exchanging cellular metabolites, and coupling electrical signals. In cancer, cells exhibit altered rates of GJIC which may play a role in neoplastic progression. K(ATP) channels help maintain membrane polarity and linkages between K(ATP) channel activity and rates of GJIC have been established. The mechanistic relationship has not been fully elucidated. We report the effects of treatment with multiple K(ATP) antagonist compounds on GJIC in metastatic cell lines demonstrating an increase in communication rates following treatment with compounds possessing specificities towards the SUR2 subunit of K(ATP). These effects remained consistent using cell lines with different expression levels of SUR1 and SUR2, suggesting possible off target effects on GJIC by these compounds.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Glimepiride, ≥98% (HPLC), solid
Sigma-Aldrich
Repaglinide, ≥98% (HPLC), solid